Natural Product Inhibitors of Hsp90: Potential Leads for Drug Discovery

被引：53
|
作者：
Amolins, M. W. [1 ]
Blagg, B. S. J. [1 ]
机构：
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2009年 / 9卷 / 02期
关键词：
Hsp90; inhibitors; cancer; neurodegenerative diseases; natural products; HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; IMPORTANT BIOLOGIC ACTIVITIES; ESCHERICHIA-COLI HSP90; MOLECULAR CHAPERONE; GELDANAMYCIN DERIVATIVES; CRYSTAL-STRUCTURE; ATP-BINDING; DNA GYRASE; ANTITUMOR-ACTIVITY;
D O I：
10.2174/138955709787316056
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Heat shock protein 90 has emerged as a promising target for the treatment of cancer and neurodegenerative diseases. This review summarizes recent advancements towards the development of natural products as they pertain to the biological and chemical understanding of this molecular chaperone.
引用
收藏
页码：140 / 152
页数：13
相关论文
共 50 条
  • [1] Natural Product Origins of Hsp90 Inhibitors
    Uehara, Yoshimasa
    [J]. CURRENT CANCER DRUG TARGETS, 2003, 3 (05) : 325 - 330
  • [2] Natural product inspired HSP90 inhibitors
    Blagg, B. S. J.
    [J]. PLANTA MEDICA, 2015, 81 (11) : 861 - 861
  • [3] Natural products as a source for the discovery of Hsp90 inhibitors
    Blagg, Brian
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [4] Hsp90 inhibitors derived from the natural product, novobiocin
    Zhao, Huiping
    Blagg, Brian S. J.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [5] Drug discovery and research of Hsp90 inhibitor
    Soga, Shiro
    Nakashima, Takayuki
    Seike, Toshihiro
    Ishii, Toshihiko
    Shiotsu, Yukimasa
    Akinaga, Shiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 36P - 36P
  • [6] Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors
    Zhang, Ming-Qiang
    Gaisser, Sabine
    Nur-E-Alam, Mohammad
    Sheehan, Lesley S.
    Vousden, William A.
    Gaitatzis, Nikolaos
    Peck, Gerrard
    Coates, Nigel J.
    Moso, Steven J.
    Radzom, Markus
    Foster, Teresa A.
    Sheridan, Rose M.
    Gregory, Matthew A.
    Roe, S. Mark
    Prodromou, Chrisostomos
    Pearl, Laurence
    Boyd, Susan M.
    Wilkinson, Barrie
    Martin, Christine J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5494 - 5497
  • [7] Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone
    Workman, P
    [J]. CANCER DETECTION AND PREVENTION, 2002, 26 (06): : 405 - 410
  • [8] Using natural product inhibitors to validate Hsp90 as a molecular target in cancer
    Neckers, Len
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) : 1163 - 1171
  • [9] Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
    Lu, Xiangyi
    Xiao, Li
    Wang, Luan
    Ruden, Douglas M.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) : 995 - 1004
  • [10] Maximizing the Therapeutic Potential of HSP90 Inhibitors
    Butler, Lisa M.
    Ferraldeschi, Roberta
    Armstrong, Heather K.
    Centenera, Margaret M.
    Workman, Paul
    [J]. MOLECULAR CANCER RESEARCH, 2015, 13 (11) : 1445 - 1451
12345